BioSpace News Archive

This latest 510(k) is the final FDA requirement needed for Biotricity to bring to market Bioflux in the US.

ADVANTIS CORPORATION CEO, Darren Cherry, took a moment to review the progress the company has made this year, and lays out an achievable set of benchmarks for the year ahead.

With reference to company announcement no. 5/2017 dated November 16, 2017 regarding the result of the IPO of Orphazyme and company announcement no. 10/2017 dated November 16, 2017, Orphazyme hereby announces that it has received the following notification pursuant to section 29 of the Danish Securities Trading Act regarding Novo Holdings A/S’ holding of shares in Orphazyme.

United Health Products today announced that it has completed an array of tests required as a part of a FDA submission.

Concept Life Sciences today announced a successful financial year, ending 2017 with revenues in excess of $65m/£49m and alsowelcomes Dr Andrew Scott as Head of Bioassay Development and Screening, and Magalie Ferbach as Business Development Director for Southern and Central Europe.

The BSPG acquisition includes multiple entities that are strategic to the future of Isodiol.

Top-line results from the study are expected by mid-2018.

Origin Agritech today released a progress update on growth platforms which are focused on the development and commercialization of superior corn seed products and high value biotechnology traits.

The board of directors of Pfizer Inc. today declared a 34-cent first-quarter 2018 dividend on the company’s common stock, payable March 1, 2018.

SENS Research Foundation announced today the receipt of a $1M bitcoin donation from the Pineapple Fund.